Thomas Taapken - 18 Mar 2026 Form 3 Insider Report for InflaRx N.V. (IFRX)

Signature
/s/ Christian Schmid, Attorney-in-Fact
Issuer symbol
IFRX
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 08:06:16 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Taapken Thomas Chief Financial Officer C/O INFLARX N.V., WINZERLAER STREET 2, JENA, GERMANY /s/ Christian Schmid, Attorney-in-Fact 18 Mar 2026 0002117357

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IFRX Ordinary Shares 3,500 18 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 150,000 $1.86 By tomtaa GmbH F1, F2
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 50,000 $1.86 By tomtaa GmbH F2, F3
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 32,002 $1.86 By tomtaa GmbH F2, F4
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 110,000 $1.86 By tomtaa GmbH F2, F5
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 55,000 $2.44 By tomtaa GmbH F2, F6
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 110,000 $2.37 By tomtaa GmbH F2, F7
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 210,000 $1.79 By tomtaa GmbH F2, F8
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 240,000 $2.41 By tomtaa GmbH F2, F9
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 240,000 $1.17 By tomtaa GmbH F2, F10
holding IFRX Performance Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 72,000 $1.17 By tomtaa GmbH F2, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on September 18, 2020 and is fully vested and exercisable as of the date hereof.
F2 The reported securities are directly held by tomtaa GmbH, a company wholly owned by the Reporting Person for which the Reporting Person acts as sole managing director. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F3 This option was granted on January 4, 2021 and is fully vested and exercisable as of the date hereof.
F4 This option was granted on July 2, 2021 and is fully vested and exercisable as of the date hereof.
F5 This option was granted on January 12, 2022 and is fully vested and exercisable as of the date hereof.
F6 This option was granted on November 21, 2022 and is fully vested and exercisable as of the date hereof.
F7 This option was granted on January 24, 2023 and is fully vested and exercisable as of the date hereof.
F8 This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof.
F9 This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof.
F10 This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 60,000 shares on each quarterly anniversary of such grant date, subject to continued service through such dates.
F11 This option shall vest depending upon achievement of the following performance criteria: (i) 50% shall vest if a certain financing event takes place before the fourth quarter of 2026 and (ii) 50% shall vest if the average Ordinary Share price for quarter four of 2026 exceeds $1.50.

Remarks:

Exhibit List - Exhibit 24.1 Power of Attorney